A database of 1023 patients with NSCLC and uncommon EGFR mutations treated with afatinib: focus on Asian patients

被引：0
|
作者：
Miura, Satoru [1 ]
Schuler, Martin [2 ,3 ]
Popat, Sanjay [4 ,5 ]
Park, Keunchil [6 ]
Passaro, Antonio
De Marinis, Filippo [7 ]
Solca, Flavio [8 ]
Maerten, Angela [9 ]
Kim, Edward S. [10 ]
Yang, James Chih-Hsin [11 ,12 ]
机构：
[1] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan
[2] Univ Duisburg Essen, West German Canc Ctr, Duisburg, Germany
[3] Partner site Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany
[4] Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England
[5] Inst Canc Res, London, England
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea
[7] European Inst Oncol IRCCS, Div Thorac Oncol, IEO, Milan, Italy
[8] Boehringer Ingelheim RCV GmbH Co KG, Vienna, Austria
[9] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[10] City Hope Natl Med Ctr, Los Angeles, CA USA
[11] Natl Taiwan Univ Canc Ctr Taipei, Dept Med Oncol, Taipei, Taiwan
[12] Natl Univ Hosp, Dept Oncol, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO29-3
引用
收藏
页码：S500 / S500
页数：1
相关论文
共 50 条
  • [1] Afatinib for the treatment of NSCLC with uncommon EGFR mutations: An updated database of 1023 cases
    Yang, J. Y. C-H.
    Schuler, M.
    Popat, S.
    Miura, S.
    Park, K.
    Passaro, A.
    de Marinis, F.
    Solca, F.
    Marten, A.
    Kim, E. S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S965 - S965
  • [2] Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases
    Yang, James Chih-Hsin
    Schuler, Martin
    Popat, Sanjay
    Miura, Satoru
    Heeke, Simon
    Park, Keunchil
    Maerten, Angela
    Kim, Edward S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 803 - 815
  • [3] Afatinib in Asian and non-Asian patients (pts) with EGFR mutation positive (EGFRm plus ) NSCLC harboring major uncommon mutations
    Yang, J. C-H.
    Schuler, M.
    Popat, S.
    Miura, S.
    Heeke, S.
    Passaro, A.
    de Marinis, F.
    Park, K.
    Kim, E. S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1396 - S1396
  • [4] Afatinib in Asian and non-Asian patients (pts) with EGFR mutation-positive (EGFRm plus ) NSCLC harboring uncommon mutations
    Yang, J. C-H.
    Schuler, M.
    Popat, S.
    Miura, S.
    Heeke, S.
    Passaro, A.
    de Marinis, F.
    Park, K.
    Kim, E. S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S860 - S861
  • [5] Afatinib in Asian and Non-Asian Patients (pts) with EGFR Mutation-Positive (EGFRm plus ) NSCLC Harboring Major Uncommon Mutations
    Yang, J. Chih-Hsin
    Schuler, M.
    Popat, S.
    Miura, S.
    Heeke, S.
    Passaro, A.
    de Marinis, F.
    Park, K.
    Kim, E. S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S31 - S31
  • [6] Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review
    Jiang, Yingying
    Fang, Xiaoxu
    Xiang, Yan
    Fang, Tingwen
    Liu, Jingwen
    Lu, Kaihua
    [J]. CURRENT ONCOLOGY, 2023, 30 (06) : 5337 - 5349
  • [7] Clinical Features and Outcomes of NSCLC Patients with Uncommon EGFR Mutations Treated with EGFRTKIs
    Tudor, R.
    Kopciuk, K.
    Dean, M.
    Gibson, A.
    Otsuka, S.
    Bebb, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S590 - S591
  • [8] EGFR Uncommon Mutations Frequency in a 1,688 NSCLC Patients Database in Brazil
    Ferreira, C.
    Zalis, M.
    Montenegro, G.
    Custodio, M.
    Zukin, M.
    Castro, G., Jr.
    Mathias, C.
    Haddad, C.
    De Lima, V.
    Araujo, L.
    Baldotto, C.
    Gelatti, A.
    Bustamante, C.
    Souza, A.
    Reis, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S157 - S157
  • [9] Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report
    Christopoulos, Petros
    Herster, Franziska
    Hoffknecht, Petra
    Falk, Markus
    Tiemann, Markus
    Kopp, Hans-Georg
    Althoff, Andre
    Stammberger, Anja
    Laack, Eckart
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] A Historical Comparison of Patients with Advanced NSCLC Harboring Uncommon EGFR Mutations Before and After the Approval of Afatinib in Japan
    Kawamura, T.
    Murakami, H.
    Kobayashi, H.
    Nakashima, K.
    Omori, S.
    Wakuda, K.
    Ono, A.
    Kenmotsu, H.
    Naito, T.
    Endo, M.
    Takahashi, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S888 - S888
12345